Skip to main content
. 2022 Apr 25;11(9):2400. doi: 10.3390/jcm11092400

Figure 6.

Figure 6

Kaplan–Meier survival analyses on PFS curves to differentiate recurrence in patients with stage IV CRC by individual and combined biomarkers. (AD) PFS curves to differentiate recurrence in patients with stage IV CRC stratified by numbers of CTC (A), presence of CTM (B), serum CEA (C), and CA19-9 levels (D). (EI) PFS curves to differentiate recurrence in patients with stage IV CRC stratified by combined biomarkers.